BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2740144)

  • 1. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas.
    Shew JY; Ling N; Yang XM; Fodstad O; Lee WH
    Oncogene Res; 1989; 4(3):205-14. PubMed ID: 2740144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblot Validation of Phospho-Specific Antibodies Using Lung Cancer Cell Lines.
    Pedreira-García WM; Pérez-Morales J; Chardón-Colón C; Cabán-Rivera J; Santiago-Cardona PG
    Methods Mol Biol; 2021; 2279():75-90. PubMed ID: 33683687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.
    Ishikawa T; Furihata M; Ohtsuki Y; Murakami H; Inoue A; Ogoshi S
    Br J Cancer; 1998; 77(1):92-7. PubMed ID: 9459151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.
    Santra M; Mann DM; Mercer EW; Skorski T; Calabretta B; Iozzo RV
    J Clin Invest; 1997 Jul; 100(1):149-57. PubMed ID: 9202067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific enzymatic dephosphorylation of the retinoblastoma protein.
    Ludlow JW; Glendening CL; Livingston DM; DeCarprio JA
    Mol Cell Biol; 1993 Jan; 13(1):367-72. PubMed ID: 8380224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease.
    Hamel W; Westphal M; Shepard HM
    J Neurooncol; 1993 May; 16(2):159-65. PubMed ID: 8289093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the retinoblastoma protein is regulated in normal human tissues.
    Cordon-Cardo C; Richon VM
    Am J Pathol; 1994 Mar; 144(3):500-10. PubMed ID: 8129035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter.
    Bondesson M; Mannervik M; Akusjärvi G; Svensson C
    Nucleic Acids Res; 1994 Aug; 22(15):3053-60. PubMed ID: 8065919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma gene structure and product expression in human gastric carcinomas.
    Constância M; Seruca R; Carneiro F; Silva F; Castedo S
    Br J Cancer; 1994 Nov; 70(5):1018-24. PubMed ID: 7947078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.
    Maandag EC; van der Valk M; Vlaar M; Feltkamp C; O'Brien J; van Roon M; van der Lugt N; Berns A; te Riele H
    EMBO J; 1994 Sep; 13(18):4260-8. PubMed ID: 7925271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor genes and their roles in breast cancer.
    Cox LA; Chen G; Lee EY
    Breast Cancer Res Treat; 1994; 32(1):19-38. PubMed ID: 7819583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression.
    Zhu X; Mancini MA; Chang KH; Liu CY; Chen CF; Shan B; Jones D; Yang-Feng TL; Lee WH
    Mol Cell Biol; 1995 Sep; 15(9):5017-29. PubMed ID: 7651420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing.
    Durfee T; Mancini MA; Jones D; Elledge SJ; Lee WH
    J Cell Biol; 1994 Nov; 127(3):609-22. PubMed ID: 7525595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
    Bookstein R; Rio P; Madreperla SA; Hong F; Allred C; Grizzle WE; Lee WH
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7762-6. PubMed ID: 2217208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.
    Huang S; Wang NP; Tseng BY; Lee WH; Lee EH
    EMBO J; 1990 Jun; 9(6):1815-22. PubMed ID: 2189724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.
    Lin BT; Gruenwald S; Morla AO; Lee WH; Wang JY
    EMBO J; 1991 Apr; 10(4):857-64. PubMed ID: 2009861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of p53 gene in human and murine osteosarcoma cells.
    Chandar N; Billig B; McMaster J; Novak J
    Br J Cancer; 1992 Feb; 65(2):208-14. PubMed ID: 1739619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.
    Figge J; Bakst G; Weisheit D; Solis O; Ross JS
    Am J Pathol; 1991 Dec; 139(6):1213-9. PubMed ID: 1721488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.